In October 2025, the Plasma Protein Therapeutic Association (PPTA) held their Plasma Protein Forum. Our North America Chair, Steven Spitalnik was one of the session speakers.
The session “Driving Awareness & Action for Anti-D” provided a thought-provoking discussion between experts, patients, and donors on the global challenges and opportunities shaping its future.
The discussion focused on the collection and use of anti-D plasma, a critical component in preventing hemolytic disease of the fetus and newborn (HDFN). The session featured medical experts, patients, and donors who shared insights on the challenges and opportunities surrounding anti-D plasma collection globally. The presentation provided an overview of current practices and offered suggestions for how to navigate this evolving and complex landscape.
